Rational dosing of gabapentin and pregabalin in chronic kidney disease

Mena Raouf1 VA Tennessee Valley Healthcare System, Murfreesboro, Nashville, TN

Timothy J Atkinson1 VA Tennessee Valley Healthcare System, Murfreesboro, Nashville, TNCorrespondence[email protected]

Meredith W Crumb1 VA Tennessee Valley Healthcare System, Murfreesboro, Nashville, TN

Jeffrey Fudin2 Stratton VA Medical Center;3 Albany College of Pharmacy and Health Sciences, Albany, NY;4 Western New England University College of Pharmacy, Springfield, MA;5 Scientific and Clinical Affairs, Remitigate LLC, Delmar, NY, USA

Pages 275-278 | Published online: 27 Jan 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

Neurontin® (gabapentin) [package insert]New York, NYParke Davis2015
Google Scholar
Lyrica® (pregabalin) [package insert]New York, NYPfizer2016
Google Scholar
BauerCSTran-Van-MinhAKadurinIDolphinACA new look at calcium channel α2δ subunitsCurr Opin Neurobiol201020556357120579869
PubMed Web of Science ®Google Scholar
BauerCSRahmanWTran-van-MinhALujanRDickensonAHDolphinACThe anti-allodynic alpha(2)delta ligand pregabalin inhibits the trafficking of the calcium channel alpha(2)delta-1 subunit to presynaptic terminals in vivoBiochem Soc Trans201038252552820298215
PubMed Web of Science ®Google Scholar
HendrichJTran Van MinhAHeblichFPharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentinProc Natl Acad Sci U S A200810593628363318299583
PubMed Web of Science ®Google Scholar
HeblichFTran Van MinhAHendrichJWatschingerKDolphinACTime course and specificity of the pharmacological disruption of the trafficking of voltage-gated calcium channels by gabapentinChannels (Austin)2008214918690052
PubMedGoogle Scholar
BockbraderHNWescheDMillerRAChapelSJaniczekNBurgerPA comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentinClin Pharmacokinet2010491066166920818832
PubMed Web of Science ®Google Scholar
Horizant® (gabapentin enacarbil extended-release) [package insert]Santa Clara, CAXenoport Inc2013
Google Scholar
Gralise® (gabapentin) [package insert]Newark, CADepomed2012
Google Scholar
UrbanTJBrownCCastroRAEffects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentinClin Pharmacol Ther200883341642117609685
PubMed Web of Science ®Google Scholar
BackonjaMBeydounAEdwardsKRGabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trialJAMA199828021183118369846777
PubMed Web of Science ®Google Scholar
SerpellMGNeuropathic pain study groupGabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trialPain200299355756612406532
PubMed Web of Science ®Google Scholar
RosenstockJTuchmanMLa MoreauxLSharmaUPregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trialPain2004110362863815288403
PubMed Web of Science ®Google Scholar
LesserHSharmaULa MoreauxLPooleRMPregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trialNeurology200463112104211015596757
PubMed Web of Science ®Google Scholar
TolleTFreynhagenRVersavelMTrostmannUYoungJPJrPregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind studyEur J Pain200812220321317631400
PubMed Web of Science ®Google Scholar
SabatowskiRGálvezRCherryDA1008-045 Study GroupPregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trialPain20041091–2263515082123
PubMed Web of Science ®Google Scholar
FreynhagenRStrojekKGriesingTWhalenEBalkenohlMEfficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimensPain2005115325426315911152
PubMed Web of Science ®Google Scholar
AymannsCKellerFMausSHartmannBCzockDReview on pharmacokinetics and pharmacodynamics and the aging kidneyClin J Am Soc Nephrol20105231432720056753
PubMed Web of Science ®Google Scholar
PichetteVLeblondFADrug metabolism in chronic renal failureCurr Drug Metab2003429110312678690
PubMed Web of Science ®Google Scholar
MatzkeGRAronoffGRAtkinsonAJJrDrug dosing consideration in patients with acute and chronic kidney disease – a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney Int201180111122113721918498
PubMed Web of Science ®Google Scholar
RowlandMTozerTNClinical Pharmacokinetics: Concepts and Applications3rdPhiladelphia, PALea & Febiger1995
Google Scholar
ZandLMcKianKPQianQGabapentin toxicity in patients with chronic kidney disease: a preventable cause of morbidityAm J Med2010123436737320362757
PubMed Web of Science ®Google Scholar
YooLMatalonDHoffmanRSGoldfarbDSTreatment of pregabalin toxicity by haemodialysis in a patient with kidney failureAm J Kidney Dis20095461127113019493601
PubMed Web of Science ®Google Scholar
BerryDJBeranRGPlunkeftMJClarkeLAHungWTThe absorption of gabapentin following high dose escalationSeizure2003121283612495646
PubMed Web of Science ®Google Scholar
BerryDMillingtonCAnalysis of pregabalin at therapeutic concentrations in human plasma/serum by reversed-phase HPLCTher Drug Monit200527445145616044101
PubMed Web of Science ®Google Scholar
BlumRAComstockTJSicaDAPharmacokinetics of gabapentin in subjects with various degrees of renal functionClin Pharmacol Ther19945621541598062491
PubMed Web of Science ®Google Scholar
RandinitisEJPosvarELAlveyCWSedmanAJCookJABockbraderHNPharmacokinetics of pregabalin in subjects with various degrees of renal functionJ Clin Pharmacol200343327728312638396
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Rational dosing of gabapentin and pregabalin in chronic kidney disease

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Rational dosing of gabapentin and pregabalin in chronic kidney disease

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date